Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...
4d
News-Medical.Net on MSNBreakthrough peptide inhibitor effective against multiple SARS-CoV-2 variantsSARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...
The following is a summary of “A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 ...
The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...
The following is a summary of “Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunity,” published in the March 2025 issue of ...
According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long ...
9d
ExtremeTech on MSNScientists Identify Antibodies That Neutralize the Virus Behind COVID-19The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...
Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...
Long COVID symptoms persisted for up to two years in more than half of the individuals who experienced the condition, according to new research published in BMC Medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results